By Michael Erman NEW YORK (Reuters) -Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical ...

Industry insights from the McDermott, Will & Schulte HPE NYC 2025 Conference on what’s driving (and challenging) PE ...

Britain wants to see more investment in the country by pharmaceutical companies if it agrees to pay higher drug prices as ...

SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to ...

The latest amendment, which has been endorsed by Congress, could be the Act’s catalyst after a year in legislative limbo.

The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay ...

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the ...

As the pharmaceutical sector grows in India, Jamkas Pharmaceuticals emerges as a reliable third-party manufacturer.

He said the government is implementing the Eighth National Development Plan (8NDP), which places science, technology, and ...

President Hakainde Hichilema has commissioned the construction of Zambia’s first-ever pharmaceutical manufacturing plant, ...